ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
BNP Paribas Issuance

BNP Paribas Issuance (P17RL8)

0.00
0.00
(0.00%)
Closed January 04 10:30AM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
-
Bid
-
Ask
-
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
-
Open
-
Last Trade
Last Trade Time
Average Volume (3m)
0.00
Financial Volume
-
VWAP
-

P17RL8 Latest News

No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
15600100.65107.189.7516102.82934132DE
26000100.65107.189.7516102.82934132DE

P17RL8 - Frequently Asked Questions (FAQ)

What is the current BNP Paribas Issuance share price?
The current share price of BNP Paribas Issuance is 0.00 €
What is the 1 year trading range for BNP Paribas Issuance share price?
BNP Paribas Issuance has traded in the range of 0.00 € to 0.00 € during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
WAMB26Ambromobiliare SpA
0.098 €
(96.00%)
53.83k
1NBNorthern Data AG
52.50 €
(30.76%)
34
EVAAskoll Eva SPA
0.17 €
(25.46%)
403k
WSOGESWarr Soges Group
0.115 €
(21.05%)
15k
WTFINTrevi Finanziaria Industriale Spa
0.89 €
(18.67%)
3.33k
WCOSMOFarmacosmo spa
0.0096 €
(-67.89%)
6.67k
COSMOFarmacosmo spa
0.668 €
(-22.86%)
338.93k
WTWL26TraWell Co SpA
0.22 €
(-21.43%)
600
GTGT Talent Group SpA
2.76 €
(-14.29%)
21.38k
WSGC28SG Company SpA
0.025 €
(-12.89%)
12.26k
TITTelecom Italia SpA
0.243 €
(-2.68%)
128.24M
ISPIntesa Sanpaolo Spa
3.849 €
(-0.03%)
47.15M
SPMSaipem Spa
2.717 €
(2.07%)
44.36M
ENELEnel Spa
7.023 €
(-0.03%)
14.4M
BPEBper Banca SPA
5.90 €
(-0.94%)
11.78M

Discussion

View Full Feed
crescentmotor crescentmotor 3 minutes ago
But in the case of Blarcamisine, "sufficient" efficacy is up for debate (given the known data).

Granted, the efficacy of Blarcamesine is still under study but, with the favorable peer review, the winds look favorable. And then what else? There's the safety question where Blarcamesi
AVXL
benz280c benz280c 4 minutes ago
Incorrect and reviling. Do better, please, in 2025.
GDVM
3331 3331 4 minutes ago
BIEL + DR. OZ + RFK = $$$
BIOELECTRONICS FLAGSHIP PRODUCT - ACTIPATCH - ON DR. OZ:
Dr. Oz devoted a whole program to explaining PEMF Pulsed ElectroMagnetic Field technology - with audience members wearing Actipatches (BIEL's flagship product) - saying it is changing the practice of med
IHuser IHuser 4 minutes ago
imo... easier to ban my narrative than counter it........ never going away AZN


AZN



IHuser
AZN
3331 3331 4 minutes ago
BIEL + DR. OZ + RFK = $$$
BIOELECTRONICS FLAGSHIP PRODUCT - ACTIPATCH - ON DR. OZ:
Dr. Oz devoted a whole program to explaining PEMF Pulsed ElectroMagnetic Field technology - with audience members wearing Actipatches (BIEL's flagship product) - saying it is changing the practice of med
harry crumb harry crumb 5 minutes ago
Oh you are from china an part of this scam,you will go down with ILLR when the SEC investigates the fraud of this company
ILLR
martyDg martyDg 5 minutes ago
Damn, I'mma put you now on my ignore list... I'm tired of seeing you stupid conspiracy theories. Effing clown.
NWBO
BDEZ BDEZ 6 minutes ago
“Everything the government says is a lie, and everything it has is stolen” ~ Nietzsche
harry crumb harry crumb 7 minutes ago
There is no desmis you moron fool! Stop lying. Tiktok is #1 an always will be, how can you lie, your mother must keep you in a closet all day with your noony in your mouth you fool
ILLR
stockinspector stockinspector 7 minutes ago
Dad'burn delightful display of doubtful detractors denying, debating and delirious!
WDLF
gawti88 gawti88 8 minutes ago
I wish you were in this riding with us, unfortunately your crew decided to short it for years and you're going to feel the pain now. When we hit 25c, I hope you don't cry.
CEOS
gawti88 gawti88 9 minutes ago
Wait; small company? lmao... dang 95 + employees isn't a small company.
CEOS
JERSEYHAWG JERSEYHAWG 9 minutes ago
Listen to this bro.
I am on no email lists and don't send email lists to anyone. Why? Cause I don't give a Flynn fuk.

That email, of stuff you said you wrote, and I believe it was sent to me. On a rare occasion zi get something sent to me. For instance this time. I don't mess
LEHNQ
jimr1717 jimr1717 10 minutes ago
This blatant scam is done
ILLR
nowwhat2 nowwhat2 11 minutes ago
Why no be just keep go up yet ?

.
XRPUSD
StayHumble StayHumble 11 minutes ago
w0w SEC🔥catches🎅🏿&👽ArtificiallyDeflating Prices 2Buy Shares"


6, 12, 2023 —

SEC charged investment adviser Sabby Management LLC & managing partner,Hal D. Mintz,w/ fraud in connection w/ a long running scheme involving misrepresenta
HMBL
elks elks 14 minutes ago
Wtf.
TWOH
fuagf fuagf 15 minutes ago
Security risk? Shrug. Trump flips on Tik Tok, because it's good for him.

PatriotTakes 🇺🇸
@patriottakes
Nikki Haley comes out against Trump’s plan to save TikTok, but won’t mention him by name

https://pbs.twimg.com/media/GgeV_fjXkAAgNe7?form
XMaster2023 XMaster2023 16 minutes ago
Roman, there could already be deals cut and the only thing we are waiting for now is approval. I actually believe this is the case and NWBO is under a gag order as BP would not want anything getting out until approval.
NWBO
JJ8 JJ8 19 minutes ago
I am encouraged of what I see of the Histogram in the Weekly Chart showing that a new uptrend appears to be in the process of developing for the AMD share price.

Hopefully that is going to continue... and lead to a share price breakout soon.

We shall see.
AMD
boi568 boi568 19 minutes ago
Anavex has delayed PD in order to wait out the development of a reliable biomarker, which has happened only during the past few months. They may also have understandably diverted some resources towards a successful MAA.
AVXL
boi568 boi568 21 minutes ago
There is no regulatory "sufficiency" test, other than being better than the standard of care, if one exists. The article makes the case that blarcamesine is better than any approved AD drug. The FDA employs a risk/benefit analysis, and you want your drug candidate to more than offset any risks with
AVXL
benz280c benz280c 21 minutes ago
Changing the innards of a Chevy with Ferrari parts is a game changer. Learn about the Z06. Maybe you will appreciate what is set to occur when the cusip, name, and ticker changes in this instance. Ignorance is alive and well by folks old enough to know better. Sad!
https://www.detroitnews.com
GDVM

Your Recent History

Delayed Upgrade Clock